Arijit Nag

Kolkata, WB, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in Waldenström Macroglobulinemia: A Single-Center Retrospective Analysis.

Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in Waldenström Macroglobulinemia: A Single-Center Retrospective Analysis.

Journal: Cureus

Published: June 03, 2026

Addressing unmet needs in chronic myeloid leukemia in chronic phase treated with two or more tyrosine kinase inhibitors: insights from literature and Indian clinical practice.

Addressing unmet needs in chronic myeloid leukemia in chronic phase treated with two or more tyrosine kinase inhibitors: insights from literature and Indian clinical practice.

Journal: Expert review of hematology

Published: December 29, 2025

Building research capacity among health care professionals in LMICs: experiences from the 9th Tata Annual Biostatistics and Research Methods Course, 2025.

Building research capacity among health care professionals in LMICs: experiences from the 9th Tata Annual Biostatistics and Research Methods Course, 2025.

Journal: Ecancermedicalscience

Published: October 09, 2025

End-of-induction MRD predicts early survival in high-risk adult B-acute lymphoblastic leukemia: A study from Eastern India.

End-of-induction MRD predicts early survival in high-risk adult B-acute lymphoblastic leukemia: A study from Eastern India.

Journal: Current problems in cancer

Published: June 11, 2025

Unusual Blast Phase Transformations in Chronic Myeloid Leukemia: A Case Series Highlighting the Diagnostic Value of Integrated Immunophenotyping.

Unusual Blast Phase Transformations in Chronic Myeloid Leukemia: A Case Series Highlighting the Diagnostic Value of Integrated Immunophenotyping.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: May 13, 2025

Bioequivalent Letermovir Usage for Prophylaxis in Haploidentical Stem Cell Transplantation at High Risk of CMV Reactivation: A Report of Two Cases From India.

Bioequivalent Letermovir Usage for Prophylaxis in Haploidentical Stem Cell Transplantation at High Risk of CMV Reactivation: A Report of Two Cases From India.

Journal: Cureus

Published: April 26, 2025

A retrospective analysis of inotuzumab ozogamicin usage in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

A retrospective analysis of inotuzumab ozogamicin usage in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

Journal: Frontiers in oncology

Published: March 28, 2025

Optimizing Treatment-Free Remission (TFR) in Chronic Myeloid Leukemia: Challenges and a Modified Monitoring Strategy - Real-World Data from Eastern India.

Optimizing Treatment-Free Remission (TFR) in Chronic Myeloid Leukemia: Challenges and a Modified Monitoring Strategy - Real-World Data from Eastern India.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: March 28, 2025

ABO-Mismatch Hematopoietic Stem Cell Transplantation with Pre-existing Red Cell Alloantibody Resembling a Case of Post-transplant Autoimmune Hemolytic Anemia.

ABO-Mismatch Hematopoietic Stem Cell Transplantation with Pre-existing Red Cell Alloantibody Resembling a Case of Post-transplant Autoimmune Hemolytic Anemia.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: August 10, 2024

Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trial.

Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trial.

Journal: The Lancet. Haematology

Published: July 19, 2024

A Brief Report on Pre-Transfusion Testing in Patients Receiving the Anti-CD38 Monoclonal Antibody for Hematological Disorders in India.

A Brief Report on Pre-Transfusion Testing in Patients Receiving the Anti-CD38 Monoclonal Antibody for Hematological Disorders in India.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: December 28, 2023

Melphalan-associated encephalopathy following autologous stem cell transplant: a transplanter's nightmare!

Melphalan-associated encephalopathy following autologous stem cell transplant: a transplanter's nightmare!

Journal: Blood cell therapy

Published: September 01, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026